Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight

NCT07467447 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Retatrutide (LY3437943)
DRUG: Placebo
BEHAVIORAL: Standardized diet and physical activity counseling throughout the study.

Sponsor

Hudson Biotech